Alternative testing momentum EPISKIN develops in vitro reconstructed human tissues and provides validated and non-validated safety and efficacy tests as alternatives to animal use, presenting a growing opportunity to supply testing platforms for cosmetics, pharmaceutical and chemical industries seeking cruelty-free options.

New formats, wider use Recent launch of SkinEthic RHE 1 cm² format expands accessibility and potential integration points for R&D teams needing scalable, smaller footprint tissue models for screening and early safety assessment.

Epithelium expansion Introduction of SkinEthic HBE human bladder epithelium model signals a broader tissue model portfolio, enabling cross-domain applications and potential upsell into dermatology, urothelial research, and product safety testing.

Training as growth Publicized 3D model training programs and validated protocols create an avenue to convert researchers and labs into repeat customers by embedding EPISKIN methodologies into routine workflows.

Global quality and scale With a production unit claiming weekly delivery of thousands of human tissues and a geographic reach across cosmetics, pharma, and chemical industries, EPISKIN offers scalable supply for large- or multi-site testing programs, appealing to firms pursuing consistent, reproducible in vitro assays.